Journal
CURRENT OPINION IN CHEMICAL BIOLOGY
Volume 70, Issue -, Pages -Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.cbpa.2022.102179
Keywords
-
Categories
Funding
- American Heart Association [826614]
- American Cancer Society [PF-20-105-01-DMC]
- Leukemia and Lymphoma Society (SCOR) [GM62437]
- NIH
Ask authors/readers for more resources
This article summarizes the research progress of classical histone deacetylases (HDACs), discussing the structure, enzymatic properties, and functional roles of these enzymes in gene expression regulation.
Classical histone deacetylases (HDACs) are enzymes that can hydrolytically cleave acetyl-Lys in histones and other proteins and serve as established drug targets in some forms of cancer. Class I HDACs 1-3 typically exist in a range of multiprotein complexes inside cells and show distinct biological functions in modulating gene expression. In recent years, it has become possible to purify and analyze the structure and enzymatic properties of several of these HDAC complexes, including CoREST, MiDAC, NuRD, Sin3, SMRT, MIER, and RERE. Here, we summarize what is experimentally established and/or computationally predicted about the structure of these complexes to describe their particular catalytic activities and sitespecificities with modified nucleosome substrates.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available